Are you passionate about nanomedicines and genetic therapies and want to use your skills to impact the development of curative and disease-modifying therapies for people with serious chronic conditions? Do you want to become part of an expanding area focused on RNA and Gene Therapies? If so, this position will be just right for you. Apply now and be part of our exciting research!
The position
As a Senior Scientist / Specialist, you will join the Non-Viral Delivery department and will support our platform and pre-clinical pipeline consisting of a variety of nucleic acid-based modalities and genome editing approaches. You will be part of a multinational and diverse team, with the purpose of developing lipid nanoparticles and other non-viral delivery solutions to advance our growing pipeline of RNA and gene therapy-based therapeutics. The position is lab-based and placed in Måløv (Copenhagen area), Denmark.
Your primary tasks will include:
The seniority level of the position will be decided based on the chosen candidate’s qualifications and experience. We welcome candidates of all experience levels to apply and grow with us.
Qualifications
We are looking for a candidate with experience and background working with lipid nanoparticles, evaluating their performance in vitro and in vivo and the development of advanced characterization assays.
To thrive and succeed in this role, we expect you to have:
As a person, you are curious and driven. You take initiative and have a can-do attitude with the ability to execute a plan and keep deadlines.
You are a dedicated team player, who consistently engages in constructive collaborations and values partnership and knowledge sharing. You thrive in a fast-paced and dynamic work environment and passionately follow external trends in the landscape of LNP delivery and clinical translation.
About the department
Non-Viral Delivery is a young department with the purpose of enabling the delivery and future development of RNA and Gene therapies. The team in Denmark works closely together with colleagues in its sister department in Lexington (MA, USA) and with the CMC area in Denmark. The department is part of the Global Nucleic Acid Therapies, which also includes legacy Dicerna.
We are developing curative and disease-modifying therapies for individuals living with serious chronic conditions, spearheaded via co-creational innovation with external partners. Treatment of disease mechanisms operating inside cells, including gene expression is enabled by emerging intracellular drug modalities. Using state-of-the-art technologies, we are building genome editing and RNA capabilities, and establishing viral and non-viral drug delivery platforms, to enable disease-specific design of impactful drugs.
Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to drive change in patient care.
Contact
For further information, please contact Erik Oude Blenke, Associate Manager of Non-Viral Delivery at [email protected]
Deadline
15th January 2025
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Husk at skrive i din ansøgning, at du så jobbet hos Ofir